Bernie Sanders criticises Danish weight-loss drug prices in the US

In a letter to the Novo Nordisk CEO, Senator Bernie Sanders calls the prices of Novo funds “scandalously high”.

Bernie Sanders is worried about the millions of Americans who cannot afford to buy Novo Nordisk’s medicine. Photo: Official website of Senator Bernie Sanders

A committee in the US Senate will investigate the pricing of the Novo Nordisk drugs Ozempic and Wegovy, Ritzau reports. At the head of the investigation of the diabetes and weight loss drug is the independent senator Bernie Sanders, who has previously sought to become the presidential candidate for the Democrats. Sanders has written a […]

Gain unlimited access to all of The Copenhagen Post

Our independent reporting can only be published with support from our readers.

Monthly subscription



(Billed once a month)

Give us a try

6 month subscription



(Billed twice a year)

Save 120 DKK

Yearly subscription



(Billed once a year)

Save 480 DKK

Save with a company subscription?